NSEGeneral Updates1d ago · 18 Aug 2026, 07:43 pm

General Updates

Jubilant Ingrevia Limited · JUBLINGREA

✦ AI Summary▲ PositiveM&A

Jubilant Ingrevia Limited has entered into a binding agreement with Zettaone Technologies India Pvt Ltd to acquire a 40% strategic stake for INR 189.2 crore, aligning with its Pinnacle growth strategy and expanding its presence in the Electronics Development and Manufacturing Services (EDMS) space.

Analysis Scores

Earnings Impact6/10
Growth Catalyst8/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment9/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Jubilant Ingrevia Limited has informed the Exchange that the Board of Directors of the Company, at its meeting held today, approved the Company's entry into a Binding Term Sheet with Zettaone Technologies India Private Limited ( Zettaone ) for the acquisition of a 40% strategic equity stake in Zettaone

Attachments (1)

📄

JUBLINGREA_18082026194258_Signed_SE_Intimation_Acquisition.pdf

pdf

Download →
View document text
August 18, 2026 BSE Limited National Stock Exchange of India Limited Floor 25, P. J. Towers, Exchange Plaza, Dalal Street, Fort Bandra Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 543271 Trading Symbol: JUBLINGREA Dear Sir/Madam, Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the ‘SEBI Listing Regulations’) Pursuant to Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No: HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 (‘SEBI Circular’), we wish to inform you that the Board of Directors of the Company, at its meeting held today, approved the Company's entry into a Binding Term Sheet with Zettaone Technologies India Private Limited (‘Zettaone’) for the acquisition of a 40% strategic equity stake in Zettaone. Following completion of the proposed acquisition, Zettaone will become an associate of the Company. The proposed investment is aligned with the Company's Pinnacle growth strategy and provides a strong platform for its play in Electronics Development and Manufacturing Services (EDMS) space. The transaction will enable the Company to deliver an integrated value proposition in electronics and semi-conductor space, leading to long-term and sustainable value creation. It will allow the Company to capitalize on its proven manufacturing and customer-centric capabilities in CDMO space, while further strengthening its engagement with customers across the electronics and semiconductor value chain. Relevant details prescribed under Regulation 30 of the SEBI Listing Regulations and SEBI Circular are enclosed as Annexure-A to this letter. The date and time of occurrence of event is August 18, 2026 at 05:30 PM (IST). We request you to take the same on record. Thanking you, Yours faithfully, For Jubilant Ingrevia Limited Deepanjali Gulati Company Secretary & Compliance Officer Encl.: as above Annexure-A Sr. No. Particulars Details 1. Name of the target entity, details in brief such Zettaone Technologies India Private as size, turnover etc. Limited 2. Whether the acquisition falls within related No party transaction(s) and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at “arm’s length” 3. Industry to which the entity being acquired Integrated electronics design and belongs manufacturing platform 4. Objects and impact of acquisition (including Company’s extension into Electronics but not limited to, disclosure of reasons for design and manufacturing systems by acquisition of target entity, if its business is leveraging our strong manufacturing and outside the main line of business of the customer centric capabilities from listed entity) CDMO business to replicate the success 5. Brief details of any governmental or Not Required regulatory approvals required for the acquisition 6. Indicative time period for completion of the The transaction is proposed to be acquisition completed in two tranches, with the first tranche expected to close by November 2026 and the second tranche expected to close by September 2027. 7. Nature of consideration - whether cash Cash Consideration consideration or share swap and details of the same 8. Cost of acquisition or the price at which the ₹ 189.2 Cr. (approximately) shares are acquired Sr. No. Particulars Details 9. Percentage of shareholding/ control 40% acquired and/ or number of shares acquired; (Proposed to acquire) 10. Brief background about the entity acquired Turnover of Zettaone during last 3 years: in terms of products/line of business FY 25-26: Rs 98.1 Cr. acquired, date of incorporation, history of FY 24-25: Rs. 79.1 Cr. last 3 years turnover, country in which the FY 23-24: Rs. 51.1 Cr. acquired entity has presence and any other significant information (in brief) Jubilant Ingrevia Limited 1A, Sector 16A, Noida – 201301, India Tel.: +91 120 4361000 www.jubilantingrevia.com PRESS RELEASE Jubilant Ingrevia Limited Enters into a Binding Agreement with Zettaone Technologies India Pvt. Ltd. for the Acquisition of a 40% Strategic Stake for INR 189.2 crore Noida, Tuesday, August 18th, 2026: Jubilant Ingrevia Limited today announced that it has entered into a binding agreement with Zettaone Technologies India Pvt Ltd. for the acquisition of a 40% strategic stake for INR 189.2 crore. Following completion of the proposed acquisition, Zettaone Technologies will become an associate company of Jubilant Ingrevia Limited. Zettaone Technologies, co-founded by Harikrishnan, Sureshkumar, Prabu and Arunkumar, is an electronics design and manufacturing platform with integrated capabilities in electronics/semicon industry. From R&D, Design and Prototyping, Manufacturing, Assembly and Box Build, the company delivers engineering excellence for Aerospace, Defence, Semi-conductor, Automotive, Medical and Industrial applications. Commenting on the acquisition, Shyam S Bhartia, Chairman, Jubilant Ingrevia Limited and Hari S Bhartia, Co- Chairman & Whole-Time Director, Jubilant Ingrevia Limited said, “The proposed investment is aligned with the Company's Pinnacle growth strategy and provides a strong platform for its play in Electronics Development and Manufacturing Services (EDMS) space. The transaction will enable the Company to deliver an integrated value proposition in electronics and semi-conductor space, leading to long-term and sustainable value creation”. The acquisition is proposed to be completed in two tranches, with the first tranche expected to close by November 2026 and the second tranche is expected to close by September 2027. Commenting on the acquisition, Deepak Jain, Chief Executive Officer and Managing Director, Jubilant Ingrevia Limited said, “We are continuously working towards advancing our strategic priorities and this acquisition is another milestone in our Pinnacle journey. We have already been expanding into high-precision semiconductor chemicals through our CDMO business and have made a great progress in last two years to establish our credibility with several global customers. The expertise in high-speed and high-power PCB design and manufacturing of Zettaone Technologies will further anchor our growing Electronics/Semiconductor business with an integrated value proposition to our customers” Harikrishnan Gopal, CEO of Zettaone Technologies Pvt. Ltd. said, “Over the years, our team has built lasting relationships through consistency, quality, and a commitment to solving complex engineering challenges. We are happy to be a part of the Jubilant Bhartia Group and this development will reinforce our position as a trusted technology partner for mission-critical electronics solutions in aerospace, defence, semi-conductor, auto, medical and industrial spaces.” This acquisition will allow the Company to capitalize on its proven manufacturing and customer-centric capabilities in CDMO space, while further strengthening its engagement with customers across the electronics and semiconductor value chain. About Jubilant Ingrevia Limited Jubilant Ingrevia Limited is a leading player in Specialty Chemicals & CDMO globally, serving Pharmaceutical, Nutrition, Agrochemical, Consumer, Semiconductor and Industrial customers. It offers customised solutions that are innovative, cost- effective and conform to global quality standards and has a broad portfolio of 130+ products. It has over 45 years of legacy in the chemicals industry and is amongst the top players globally in Pyridine & Picolines, Pyridine derivatives, Acetic Anhydride, Vitamin-B3 and many other products. Jubilant Ingrevia Limited has a fast-growing Custom Development and Manufacturing business (CDMO) serving pharmaceuticals, agrochemicals and semiconductor sectors. The Company serves customers in US, EU, Japan, Middle East, South East Asia and other geographies, in addition to domestic market from [Showing first 8,000 characters — download PDF for full document]